Human neutrophil peptides mediate endothelial-monocyte interaction, foam cell formation, and platelet activation

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 31, Issue 9, 2011, Pages 2070-2079

  Quinn, Kieran L ^a,b,c   Henriques, Melanie ^a,b,c   Tabuchi, Arata ^a,b,d   Han, Bing ^a,b,c   Yang, Hong ^a,b   Cheng, Wei Erh ^a,b,c   Tole, Soumitra ^e   Yu, Hanpo ^a,b,c   Luo, Alice ^a,b,c   Charbonney, Emmanuel ^a,d   Tullis, Elizabeth ^a,c   Lazarus, Alan ^a,b   Robinson, Lisa A ^e   Ni, Heyu ^a,b   Peterson, Blake R ^f   Kuebler, Wolfgang M ^a,d   Slutsky, Arthur S ^a,c   Zhang, Haibo ^a,b,c  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b Department of Physiology ^*  (Canada)

^c Interdepartmental Division of Critical Care Medicine   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e HOSPITAL FOR SICK CHILDREN   (Canada)

^f UNIVERSITY OF KANSAS   (United States)

Author keywords

atherosclerosis; leukocytes; transgenic models

Indexed keywords

CELL PROTEIN; HUMAN NEUTROPHIL PEPTIDE; LOW DENSITY LIPOPROTEIN RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 8; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RESPONSE; CELL ADHESION; CELL INTERACTION; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FOAM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LEUKOCYTE; MALE; MONOCYTE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOGENESIS;

ALPHA-DEFENSINS; ANIMALS; ATHEROSCLEROSIS; CELL COMMUNICATION; CHEMOKINES; ENDOTHELIAL CELLS; FOAM CELLS; HUMANS; LDL-RECEPTOR RELATED PROTEIN 1; LDL-RECEPTOR RELATED PROTEINS; MALE; MICE; MONOCYTES; NEUTROPHIL ACTIVATION; OXIDATIVE STRESS; PLATELET ACTIVATION; PLATELET AGGREGATION;

EID: 80052185689     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.111.227116     Document Type: Article

References (54)

1. Dorweiler B, Torzewski M, Dahm M, Kirkpatrick CJ, Lackner K, Vahl C. Subendothelial infiltration of neutrophil granulocytes and liberation of matrix-destabilizing enzymes in an experimental model of human neointima. Thromb Haemost. 2008;99:373-381. (Pubitemid 351230969)
2. van Leeuwen M, Gijbels MJ, Duijvestijn A, Smook M, van de Gaar MJ, Heeringa P, de Winther MP, Tervaert JW. Accumulation of myeloperoxidase-positive neutrophils in atherosclerotic lesions in LDLR mice. Arterioscler Thromb Vasc Biol. 2008;28:84-89.
3. Zernecke A, Bot I, Djalali-Talab Y, Shagdarsuren E, Bidzhekov K, Meiler S, Krohn R, Schober A, Sperandio M, Soehnlein O, Bornemann J, Tacke F, Biessen EA, Weber C. Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis. Circ Res. 2008;102:209-217. (Pubitemid 351651125)
4. Baetta R, Corsini A. Role of polymorphonuclear neutrophils in atherosclerosis: current state and future perspectives. Atherosclerosis. 2009; 210:1-13.
5. Rotzius P, Soehnlein O, Kenne E, Lindbom L, Nystrom K, Thams S, Eriksson E. ApoE/lysozyme MEGFP/EGFP mice as a versatile model to study monocyte and neutrophil trafficking in atherosclerosis. Atherosclerosis. 2009;202:111-118.
6. Naruko T, Ueda M, Haze K, van der Wal AC, van der Loos CM, Itoh A, Komatsu R, Ikura Y, Ogami M, Shimada Y, Ehara S, Yoshiyama M, Takeuchi K, Yoshikawa J, Becker AE. Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation. 2002;106:2894-2900. (Pubitemid 35424738)
7. Avanzas P, Arroyo-Espliguero R, Cosín-Sales J, Aldama G, Pizzi C, Quiles J, Kaski JC. Markers of inflammation and multiple complex stenoses (pancoronary plaque vulnerability) in patients with non-ST segment elevation acute coronary syndromes. Heart. 2004;90:847-852. (Pubitemid 39022574)
8. Ovbiagele B, Lynn MJ, Saver JL, Chimowitz MI. Leukocyte count and vascular risk in symptomatic intracranial atherosclerosis. Cerebrovasc Dis. 2007;24:283-288. (Pubitemid 47295598)
9. Coller BS. Leukocytosis and ischemic vascular disease morbidity and mortality: is it time to intervene? Arterioscler Thromb Vasc Biol. 2005; 25:658-670. (Pubitemid 40463851)
10. Kawaguchi H, Mori T, Kawano T, Kono S, Sasaki J, Arakawa K. Band neutrophil count and the presence and severity of coronary atherosclerosis. Am Heart J. 1996;132:9-12. (Pubitemid 26243686)
11. Sweetnam PM, Thomas HF, Yarnell JW, Baker IA, Elwood PC. Total and differential leukocyte counts as predictors of ischemic heart disease: the Caerphilly and Speedwell studies. Am J Epidemiol. 1997;145:416-421. (Pubitemid 27084213)
12. Kaski JC, Avanzas P, Arroyo-Espliguero R. Neutrophil count and complex lesions in patients with coronary artery disease. Arterioscler Thromb Vasc Biol. 2005;25:e112; author reply e112.
13. Rho YH, Chung CP, Oeser A, Solus J, Asanuma Y, Sokka T, Pincus T, Raggi P, Gebretsadik T, Shintani A, Stein CM. Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis. Arthritis Rheum. 2009;61:1580-1585.
14. Rotzius P, Thams S, Soehnlein O, Kenne E, Tseng CN, Bjorkstrom NK, Malmberg KJ, Lindbom L, Eriksson EE. Distinct Infiltration of Neutrophils in Lesion Shoulders in ApoE Mice. Am J Pathol. 2010;177: 493-500.
15. Lee TD, Gonzalez ML, Kumar P, Chary-Reddy S, Grammas P, Pereira HA. CAP37, a novel inflammatory mediator: its expression in endothelial cells and localization to atherosclerotic lesions. Am J Pathol. 2002;160: 841-848. (Pubitemid 34224574)
16. Ganz T, Lehrer RI. Defensins. Curr Opin Immunol. 1994;6:584-589. (Pubitemid 24249516)
17. Rehaume LM, Hancock RE. Neutrophil-derived defensins as modulators of innate immune function. Crit Rev Immunol. 2008;28:185-200.
18. Rodriguez-Garcia M, Oliva H, Climent N, Garcia F, Gatell JM, Gallart T. Human immature monocyte-derived dendritic cells produce and secrete-defensins 1-3. J Leukoc Biol. 2007;82:1143-1146. (Pubitemid 350133510)
19. Kokryakov VN, Harwig SS, Panyutich EA, Shevchenko AA, Aleshina GM, Shamova OV, Korneva HA, Lehrer RI. Protegrins: leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins. FEBS Lett. 1993;327:231-236. (Pubitemid 23211194)
20. Quinn K, Henriques M, Parker T, Slutsky AS, Zhang H. Human neutrophil peptides: a novel potential mediator of inflammatory cardiovascular diseases. Am J Physiol Heart Circ Physiol. 2008;295: H1817-H1824.
21. Ihi T, Nakazato M, Mukae H, Matsukura S. Elevated concentrations of human neutrophil peptides in plasma, blood, and body fluids from patients with infections. Clin Infect Dis. 1997;25:1134-1140.
22. Panyutich AV, Panyutich EA, Krapivin VA, Baturevich EA, Ganz T. Plasma defensin concentrations are elevated in patients with septicemia or bacterial meningitis. J Lab Clin Med. 1993;122:202-207. (Pubitemid 23239152)
23. Barnathan ES, Raghunath PN, Tomaszewski JE, Ganz T, Cines DB, Higazi Aa-R. Immunohistochemical localization of defensin in human coronary vessels. Am J Pathol. 1997;150:1009-1020. (Pubitemid 27106172)
24. Higazi AA, Lavi E, Bdeir K, Ulrich AM, Jamieson DG, Rader DJ, Usher DC, Kane W, Ganz T, Cines DB. Defensin stimulates the binding of lipoprotein (a) to human vascular endothelial and smooth muscle cells. Blood. 1997;89:4290-4298. (Pubitemid 27260236)
25. Nassar H, Lavi E, Akkawi S, Bdeir K, Heyman SN, Raghunath PN, Tomaszewski J, Higazi AA.-Defensin: link between inflammation and atherosclerosis. Atherosclerosis. 2007;194:452-457.
26. Krylov AV, Kisseleva EP, Aleshina GM, Shamova OV, Kokryakov VN. Effects of defensin and lactoferrin on functional activity of endothelial cells in vitro. Bull Exp Biol Med. 2007;144:331-334.
27. Kougias P, Chai H, Lin PH, Yao Q, Lumsden AB, Chen C. Neutrophil antimicrobial peptide-defensin causes endothelial dysfunction in porcine coronary arteries. J Vasc Surg. 2006;43:357-363. (Pubitemid 43221934)
28. Syeda F, Tullis E, Slutsky AS, Zhang H. Human neutrophil peptides upregulate expression of COX-2 and endothelin-1 by inducing oxidative stress. Am J Physiol Heart Circ Physiol. 2008;294:H2769-H2774.
29. Bdeir K, Cane W, Canziani G, Chaiken I, Weisel J, Koschinsky ML, Lawn RM, Bannerman PG, Sachais BS, Kuo A, Hancock MA, Tomaszewski J, Raghunath PN, Ganz T, Higazi AA, Cines DB. Defensin promotes the binding of lipoprotein (a) to vascular matrix. Blood. 1999; 94:2007-2019. (Pubitemid 29430417)
30. Higazi AA, Nassar T, Ganz T, Rader DJ, Udassin R, Bdeir K, Hiss E, Sachais BS, Williams KJ, Leitersdorf E, Cines DB. The-defensins stimulate proteoglycan-dependent catabolism of low-density lipoprotein by vascular cells: a new class of inflammatory apolipoprotein and a possible contributor to atherogenesis. Blood. 2000;96:1393-1398. (Pubitemid 30658469)
31. Nassar T, Akkawi S, Bar-Shavit R, Haj-Yehia A, Bdeir K, Al-Mehdi AB, Tarshis M, Higazi AA. Human-defensin regulates smooth muscle cell contraction: a role for low-density lipoprotein receptor-related protein/2-macroglobulin receptor. Blood. 2002;100:4026-4032. (Pubitemid 35396869)
32. Khine AA, Del Sorbo L, Vaschetto R, Voglis S, Tullis E, Slutsky AS, Downey GP, Zhang H. Human neutrophil peptides induce interleukin-8 production through the P2Y6 signaling pathway. Blood. 2006;107: 2936-2942.
33. Vaschetto R, Grinstein J, Del Sorbo L, Khine AA, Voglis S, Tullis E, Slutsky AS, Zhang H. Role of human neutrophil peptides in the initial interaction between lung epithelial cells and CD4 lymphocytes. J Leukoc Biol. 2007;81:1022-1031. (Pubitemid 46495651)
34. Shashkin P, Dragulev B, Ley K. Macrophage differentiation to foam cells. Curr Pharm Des. 2005;11:3061-3072. (Pubitemid 41158090)
35. Stein S, Lohmann C, Schafer N, Hofmann J, Rohrer L, Besler C, Rothgiesser KM, Becher B, Hottiger MO, Boren J, McBurney MW, Landmesser U, Luscher TF, Matter CM. SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis. Eur Heart J. 31:2301-2309.
36. Zhang J, Cai S, Peterson BR, Kris-Etherton PM, Heuvel JP. Development of a cell-based, high-throughput screening assay for cholesterol efflux using a fluorescent mimic of cholesterol. Assay Drug Dev Technol. 2011;9:136-146.
37. Reheman A, Yang H, Zhu G, Jin W, He F, Spring CM, Bai X, Gross PL, Freedman J, Ni H. Plasma fibronectin depletion enhances platelet aggregation and thrombus formation in mice lacking fibrinogen and von Willebrand factor. Blood. 2009;113:1809-1817.
38. Zhang H, Porro G, Orzech N, Mullen B, Liu M, Slutsky AS. Neutrophil defensins mediate acute inflammatory response and lung dysfunction in dose-related fashion. Am J Physiol Lung Cell Mol Physiol. 2001;280: L947-L954.
39. Kuebler WM, Kuhnle GE, Groh J, Goetz AE. Leukocyte kinetics in pulmonary microcirculation: intravital fluorescence microscopic study. J Appl Physiol. 1994;76:65-71. (Pubitemid 24048227)
40. Riddell DR, Vinogradov DV, Stannard AK, Chadwick N, Owen JS. Identification and characterization of LRP8 (apoER2) in human blood platelets. J Lipid Res. 1999;40:1925-1930. (Pubitemid 29477264)
41. Soehnlein O, Weber C. Myeloid cells in atherosclerosis: initiators and decision shapers. Semin Immunopathol. 2009;31:35-47.
42. Roman RM, Camargo PV, Borges FK, Rossini AP, Polanczyk CA. Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients. Coron Artery Dis. 2010; 21:129-136.
43. Zaric J, Ruegg C. Integrin-mediated adhesion and soluble ligand binding stabilize COX-2 protein levels in endothelial cells by inducing expression and preventing degradation. J Biol Chem. 2005;280:1077-1085.
44. Daugherty A, Webb NR, Rateri DL, King VL. Thematic review series: the immune system and atherogenesis: cytokine regulation of macrophage functions in atherogenesis. J Lipid Res. 2005;46:1812-1822. (Pubitemid 41248477)
45. Soehnlein O, Weber C, Lindbom L. Neutrophil granule proteins tune monocytic cell function. Trends Immunol. 2009;30:538-546.
46. Lindemann S, Kramer B, Seizer P, Gawaz M. Platelets, inflammation and atherosclerosis. J Thromb Haemost. 2007;5(suppl 1):203-211. (Pubitemid 46958835)
47. Bigalke B, Lindemann S, Ehlers R, Seizer P, Daub K, Langer H, Schonberger T, Kremmer E, Siegel-Axel D, May AE, Gawaz M. Expression of platelet collagen receptor glycoprotein VI is associated with acute coronary syndrome. Eur Heart J. 2006;27:2165-2169. (Pubitemid 44412829)
48. Huo Y, Schober A, Forlow SB, Smith DF, Hyman MC, Jung S, Littman DR, Weber C, Ley K. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med. 2003;9:61-67. (Pubitemid 36098261)
49. Spijkers PP, da Costa Martins P, Westein E, Gahmberg CG, Zwaginga JJ, Lenting PJ. LDL-receptor-related protein regulates2-integrin-mediated leukocyte adhesion. Blood. 2005;105:170-177. (Pubitemid 40053079)
50. Bdeir K, Higazi AA, Kulikovskaya I, Christofidou-Solomidou M, Vinogradov SA, Allen TC, Idell S, Linzmeier R, Ganz T, Cines DB. Neutrophil-defensins cause lung injury by disrupting the capillary-epithelial barrier. Am J Respir Crit Care Med. 2010;181:935-946.
51. Yang H, Lang S, Zhai Z, Li L, Kahr WH, Chen P, Brkic J, Spring CM, Flick MJ, Degen JL, Freedman J, Ni H. Fibrinogen is required for maintenance of platelet intracellular and cell-surface P-selectin expression. Blood. 2009;114:425-436.
52. Totani L, Evangelista V. Platelet-leukocyte interactions in cardiovascular disease and beyond. Arterioscler Thromb Vasc Biol. 2010;30:2357-2361.
53. Evangelho JS, Casali KR, Campos C, De Angelis K, Veiga AB, Rigatto K. Hypercholesterolemia magnitude increases sympathetic modulation and coagulation in LDLr knockout mice. Auton Neurosci. 2011;159: 98-103.
54. Robertson JO, Li W, Silverstein RL, Topol EJ, Smith JD. Deficiency of LRP8 in mice is associated with altered platelet function and prolonged time for in vivo thrombosis. Thromb Res. 2009;123:644-652.